LONDON (Reuters) - The U.S. drugs regulator has rejected goods manufacturer Reckitt Benckiser's call for stricter packaging for its heroin addiction treatment, instead approving generic production for the drug. The British company's pharmaceuticals division makes most of its profit from Suboxone, a treatment containing buprenorphine, for recovering heroin addicts. Last year, Reckitt voluntarily withdrew the sale of Suboxone tablets in the U.S. in favor of an individually sealed film version, citing a higher risk of children mistakenly getting their hands on the tablets. ... via Health News Headlines - Yahoo! News Read More Here..
No comments:
Post a Comment